Naoki Hirokawa1, Kazumitsu Koito2, Futoshi Okada3, Nobuki Kudo4, Katsuyuki Yamamoto4, Katsuhiko Fujimoto5, Mutsumi Nishida6, Takeshi Ichimura2, Masakazu Hori2, Taishi Satoh2, Masato Hareyama2. 1. Department of Radiology, School of Medicine, Sapporo Medical University, Minami-1, Nishi-16, Chuo-ku, Sapporo, 060-8543, Japan. nhirokaw@sapmed.ac.jp. 2. Department of Radiology, School of Medicine, Sapporo Medical University, Minami-1, Nishi-16, Chuo-ku, Sapporo, 060-8543, Japan. 3. Department of Biomolecular Function, Graduate School of Medicine, Yamagata University, Yamagata, 990-9585, Japan. 4. Laboratory of Biochemical Instrumentation & Measurements Research Associate, Graduate School of Engineering, Hokkaido University, Sapporo, 060-8628, Japan. 5. Toshiba Medical Systems Corporation, Ohtawara, 324-8550, Japan. 6. Division of Clinical Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, 060-8628, Japan.
Abstract
PURPOSE: The purpose of the present study is to investigate anticancer efficacy and apoptosis confirmed by caspase under several exposure conditions of high-intensity focused ultrasound (HIFU). MATERIALS AND METHODS: Twenty-five rats with KDH-8 hepatoma were treated by HIFU at several acoustic energies to evaluate treatment efficacy. Apoptosis was examined by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and Hoechst 33258 staining, and caspase 3, 8, and 9/6 activity was respectively assayed. RESULTS: The KDH-8 subcutaneous tumors were reduced by HIFU, and these rats survived longer than the nontreatment rats (P < 0.01). The minimal threshold of HIFU energy was 30 W × 1.0 s for tumor control and long-term survival. The tumors exposed to HIFU exhibited marked apoptotic features under conditions of less than 10 W × 1.0 s. In cultured KDH-8 cells, apoptosis was caused at less than 30 W × 1.0 s (P < 0.01), and more was induced as the energy went down. Caspase 3, 8, and 9/6 were more activated at low energy under 10 W × 1.0 s (P < 0.01), and caspase 8, which is death receptor dependent, was significantly more activated than caspase 9/6, which is mitochondria dependent (P < 0.01). CONCLUSION: HIFU-induced apoptosis in vivo and in vitro is one of the mechanisms for tumor control and is mediated by caspase 3, 8, and 9/6. The significantly greater activation of caspase 8 than of caspase 9/6 suggests that the apoptosis pathway induced by HIFU might be more mitochondria dependent than death receptor dependent. However, further examination will be needed.
PURPOSE: The purpose of the present study is to investigate anticancer efficacy and apoptosis confirmed by caspase under several exposure conditions of high-intensity focused ultrasound (HIFU). MATERIALS AND METHODS: Twenty-five rats with KDH-8 hepatoma were treated by HIFU at several acoustic energies to evaluate treatment efficacy. Apoptosis was examined by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and Hoechst 33258 staining, and caspase 3, 8, and 9/6 activity was respectively assayed. RESULTS: The KDH-8 subcutaneous tumors were reduced by HIFU, and these rats survived longer than the nontreatment rats (P < 0.01). The minimal threshold of HIFU energy was 30 W × 1.0 s for tumor control and long-term survival. The tumors exposed to HIFU exhibited marked apoptotic features under conditions of less than 10 W × 1.0 s. In cultured KDH-8 cells, apoptosis was caused at less than 30 W × 1.0 s (P < 0.01), and more was induced as the energy went down. Caspase 3, 8, and 9/6 were more activated at low energy under 10 W × 1.0 s (P < 0.01), and caspase 8, which is death receptor dependent, was significantly more activated than caspase 9/6, which is mitochondria dependent (P < 0.01). CONCLUSION:HIFU-induced apoptosis in vivo and in vitro is one of the mechanisms for tumor control and is mediated by caspase 3, 8, and 9/6. The significantly greater activation of caspase 8 than of caspase 9/6 suggests that the apoptosis pathway induced by HIFU might be more mitochondria dependent than death receptor dependent. However, further examination will be needed.
Authors: Amiya P Sinha Hikim; Yanhe Lue; Cindy M Yamamoto; Yanira Vera; Susana Rodriguez; Pauline H Yen; Kevin Soeng; Christina Wang; Ronald S Swerdloff Journal: Endocrinology Date: 2003-07 Impact factor: 4.736
Authors: F Firestein; L A Rozenszajn; L Shemesh-Darvish; R Elimelech; J Radnay; U Rosenschein Journal: Ann N Y Acad Sci Date: 2003-12 Impact factor: 5.691
Authors: A Sibille; F Prat; J Y Chapelon; F abou el Fadil; L Henry; Y Theilliere; T Ponchon; D Cathignol Journal: Ultrasound Med Biol Date: 1993 Impact factor: 2.998